© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 11, 911-913,
June 2, 1999
© 1999 Oxford University Press
NEWS |
Can Skin Cancers Be Minimized or Prevented in Organ Transplant Patients?
Serious skin cancers recognized for 30 years as a problem for organ transplant recipients might be prevented by reducing the immunosuppressive drugs transplant patients take, or by eliminating them altogether over time, according to Thomas Starzl, M.D., Ph.D., director of the Thomas E. Starzl Transplantation Institute at the University of Pittsburgh, and a pioneer in the transplantation field.
|
In a recent interview,
Alarming Numbers
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. M. Welsh, K. M. Applebaum, S. K. Spencer, A. E. Perry, M. R. Karagas, and H. H. Nelson CTLA4 Variants, UV-Induced Tolerance, and Risk of Non-Melanoma Skin Cancer Cancer Res., August 1, 2009; 69(15): 6158 - 6163. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Welsh, M. R. Karagas, K. M. Applebaum, S. K. Spencer, A. E. Perry, and H. H. Nelson A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions Carcinogenesis, October 1, 2008; 29(10): 1950 - 1954. [Abstract] [Full Text] [PDF] |
||||


